Who owns the CYCLIS PHARMACEUTICALS trademark?

The CYCLIS PHARMACEUTICALS trademark is owned by Cyclis Pharmaceuticals, Inc..

What class is the CYCLIS PHARMACEUTICALS trademark registered in?

The CYCLIS PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CYCLIS PHARMACEUTICALS?

The USPTO serial number for CYCLIS PHARMACEUTICALS is 76398731.

What is the registration number for CYCLIS PHARMACEUTICALS?

CYCLIS PHARMACEUTICALS is registered under USPTO registration number 2700034.

CYC

USPTO Trademark Record

ABANDONED

CYCLIS PHARMACEUTICALS

SN 76398731·Reg 2700034·Filed Apr 22, 2002

Owner Cyclis Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CYCLIS PHARMACEUTICALS (Serial No. 76398731), Registration No. 2700034, is a abandoned US trademark filed on Apr 22, 2002 by Cyclis Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

CYCLIS PHARMACEUTICALS (Reg. #2700034) is an abandoned US trademark that was filed in 2002 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 22, 2002

SERIAL

76398731

REG#

2700034

REGISTERED

Mar 25, 2003

Owner

Applicant

Cyclis Pharmaceuticals, Inc.

Entity

Corporation

State

Address

333 Providence Highway, Norwood, MA, 02062

Country

Attorney

NameChristine M. Baker, Esquire

Law firm

CYCLIS PHARMACEUTICALS INC

Docket

22596-401 [C

Address

333 PROVIDENCE HWY, NORWOOD, MA 02062, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateApr 22, 2002

Serial Number76398731

Registration No.2700034

Registration DateMar 25, 2003

Status DateJan 19, 2005

Published for OppositionDec 31, 2002

Mark TypeTypeset (words/letters/numbers)

Attorney Docket22596-401 [C

Status DescriptionDead and cancelled, Section 18

Filing Signals

FILED

2002

YEARS AGO

24y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Apr 10, 2002

First use in commerce: Apr 10, 2002

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

CANCELLATION TERMINATED NO. 999999

Jan 19, 2005

CANCELLATION TERMINATED NO. 999999

CANCELLED SECTION 18-TOTAL

Jan 19, 2005

CANCELLED SECTION 18-TOTAL

CANCELLATION GRANTED NO. 999999

Nov 22, 2004

CANCELLATION GRANTED NO. 999999

CANCELLATION INSTITUTED NO. 999999

May 19, 2004

CANCELLATION INSTITUTED NO. 999999

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 13, 2003

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Mar 25, 2003

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Dec 31, 2002

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Dec 11, 2002

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 09, 2002

APPROVED FOR PUB - PRINCIPAL REGISTER

PAPER RECEIVED

Sep 13, 2002

PAPER RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 13, 2002

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION MAILED

Aug 23, 2002

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Aug 14, 2002

ASSIGNED TO EXAMINER

CYCLIS PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Cyclis Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christine M. Baker, Esquire

Resources

Company